期刊
NATURE REVIEWS CANCER
卷 13, 期 11, 页码 772-787出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3612
关键词
-
类别
资金
- US National Institutes of Health (NIH) [5R01CA164273-02]
- V Foundation for Cancer Research
- Uniting Against Lung Cancer
Chromosomal rearrangements that lead to oncogenic kinase activation are observed in many epithelial cancers. These cancers express activated fusion kinases that drive the initiation and progression of malignancy, and often have a considerable response to small-molecule kinase inhibitors, which validates these fusion kinases as 'druggable' targets. In this Review, we examine the aetiologic, pathogenic and clinical features that are associated with cancers harbouring oncogenic fusion kinases, including anaplastic lymphoma kinase (ALK), ROS1 and RET. We discuss the clinical outcomes with targeted therapies and explore strategies to discover additional kinases that are activated by chromosomal rearrangements in solid tumours.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据